4 unknown. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Unknown 4 |
Follow Myeloma: new trials by email Literature Review of Myeloma trials Research Report on Myeloma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of PET 18F-Fludarabine for the Initial Assessment and End-treatment of Symptomatic Multiple Myeloma Patients 18F-Fludarabine - Myeloma | Phase 1 | Unknown | Nantes University Hospital | 35 | 2022-09-09 | 2024-06-14 |
| Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies Autologous CAR-T cells, Fludarabine, Cyclophosphamide - Relapsed/Refractory Hematological Malignancies, Lymphoma | Phase 1 | Unknown | The Affiliated People's Hospital of Ningbo University | 10 | 2021-09-16 | 2022-09-06 |
| Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell Transplantation CD62L- Tem - Lymphoma, Leukemia | Phase 1 | Unknown | University College, London | 18 | 2019-10-21 | 2019-10-25 |
| Atorvastatin in Myeloma atorvastatin - Myeloma | Phase 1 | Unknown | Bayside Health | 2006-10-11 |
Neoplasms, Plasma Cell (4) · Leukemia (2) · Lymphoma (2) · Anemia, Aplastic (1) · Graft vs Host Disease (1) · Hematologic Neoplasms (1) · Myelodysplastic Syndromes (1) · Primary Immunodeficiency Diseases (1)
Neoplasms (4) · Neoplasms by Histologic Type (4) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Lymphatic Diseases (2) · Lymphoproliferative Disorders (2) · Anemia (1) · Bone Marrow Diseases (1) · Bone Marrow Failure Disorders (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Immunologic Deficiency Syndromes (1) · Neoplasms by Site (1)
Atorvastatin (1) · Cyclophosphamide (1) · fludarabine (1) · fludarabine phosphate (1)
Bayside Health (1) · Nantes University Hospital (1) · The Affiliated People's Hospital of Ningbo University (1) · University College, London (1)
Australia (1) · China (1) · France (1) · United Kingdom (1)
Andrew Spencer, MBChB, FRACP, PhD (1) · Ying Lu (1)